Several studies havesuggested that approximately 20% of uniformly distributed dystrophin may be sufficient(29,30) andmore recent work has shown that very low residual dystrophin quantity was associated withmilder dystrophinopathy (31). The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.